Response of the Catalonia neonatal screening laboratory to the pandemic of SARS-CoV-2.
Faced with the prospect of a collapsed health system due to the COVID-19 pandemic, the professionals involved in the Neonatal Screening Programme (NSP) of Catalonia had to adapt to this situation in a flexible, forceful and efficient manner. The most important goals were to prevent the risk of infection in the professionals, in families and their newborns, as well as to ensure the same effectiveness for the early detection of the diseases included in our programme. To this end, the laboratory was reorganised by dividing the staff into groups and the spaces were redistributed. It was also necessary to modify several protocols and circuits, especially for the management of early discharges from maternity centres, and for the collection of the necessary second samples (from newborns with inconclusive results or for low quality samples). In general, a 36% reduction in the time of arrival of these second samples at the laboratory was achieved with respect to the previous circuit. In the specific case of cystic fibrosis detection, the implementation of a new strategy meant a 100% reduction in the request for second samples and a 70% reduction in the age of diagnosis of the newborn. After evaluating these changes, it can be concluded that in the face of the pandemic, the NSP of Catalonia showed determined leadership, aligning all its professionals, ensuring the continuity of the activity in the programme and generating new opportunities. The new processes and circuits implemented have been definitively consolidated, improving the efficiency of the programme.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
|---|---|
| Enthalten in: |
Revista espanola de salud publica - 94(2020) vom: 16. Dez. |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Respuesta del Laboratorio de Cribado Neonatal de Cataluña ante la pandemia por SARS-CoV-2 |
|---|
| Beteiligte Personen: |
Argudo Ramírez, Ana [VerfasserIn] |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 04.01.2021 Date Revised 04.01.2021 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM318890496 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318890496 | ||
| 003 | DE-627 | ||
| 005 | 20231225170313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||spa c | ||
| 028 | 5 | 2 | |a pubmed24n1062.xml |
| 035 | |a (DE-627)NLM318890496 | ||
| 035 | |a (NLM)33323921 | ||
| 035 | |a (PII)e202012165 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Argudo Ramírez, Ana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Response of the Catalonia neonatal screening laboratory to the pandemic of SARS-CoV-2. |
| 246 | 3 | 3 | |a Respuesta del Laboratorio de Cribado Neonatal de Cataluña ante la pandemia por SARS-CoV-2 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.01.2021 | ||
| 500 | |a Date Revised 04.01.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Faced with the prospect of a collapsed health system due to the COVID-19 pandemic, the professionals involved in the Neonatal Screening Programme (NSP) of Catalonia had to adapt to this situation in a flexible, forceful and efficient manner. The most important goals were to prevent the risk of infection in the professionals, in families and their newborns, as well as to ensure the same effectiveness for the early detection of the diseases included in our programme. To this end, the laboratory was reorganised by dividing the staff into groups and the spaces were redistributed. It was also necessary to modify several protocols and circuits, especially for the management of early discharges from maternity centres, and for the collection of the necessary second samples (from newborns with inconclusive results or for low quality samples). In general, a 36% reduction in the time of arrival of these second samples at the laboratory was achieved with respect to the previous circuit. In the specific case of cystic fibrosis detection, the implementation of a new strategy meant a 100% reduction in the request for second samples and a 70% reduction in the age of diagnosis of the newborn. After evaluating these changes, it can be concluded that in the face of the pandemic, the NSP of Catalonia showed determined leadership, aligning all its professionals, ensuring the continuity of the activity in the programme and generating new opportunities. The new processes and circuits implemented have been definitively consolidated, improving the efficiency of the programme | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Catalonia Newborn Screening Program | |
| 650 | 4 | |a Newborn screening | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Spain | |
| 700 | 1 | |a González de Aledo Castillo, José Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Marín Soria, José Luis |e verfasserin |4 aut | |
| 700 | 1 | |a López Galera, Rosa María |e verfasserin |4 aut | |
| 700 | 1 | |a Pajares García, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Richard, Sabine |e verfasserin |4 aut | |
| 700 | 1 | |a Bádenas Orquín, Célia |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez Bueno, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Falguera Puig, Gemma |e verfasserin |4 aut | |
| 700 | 1 | |a Prats Viedma, Blanca |e verfasserin |4 aut | |
| 700 | 1 | |a Asso Ministral, Laia |e verfasserin |4 aut | |
| 700 | 1 | |a García Villoria, Judit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista espanola de salud publica |d 1998 |g 94(2020) vom: 16. Dez. |w (DE-627)NLM074740377 |x 2173-9110 |7 nnns |
| 773 | 1 | 8 | |g volume:94 |g year:2020 |g day:16 |g month:12 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 94 |j 2020 |b 16 |c 12 | ||